Candida auris is a multidrug-resistant fungal pathogen that is associated with nosocomial outbreaks in patients with extensive health care exposure and treatment outside the United States. The Ohio Department of Health recommends C auris screening in high-risk patients. However, this can be operationally difficult for many health care facilities. This report describes a C auris and carbapenem-resistant Enterobacterales inpatient screening program done in collaboration with state public health.
Keyphrases
- public health
- healthcare
- candida albicans
- multidrug resistant
- end stage renal disease
- mental health
- palliative care
- ejection fraction
- chronic kidney disease
- newly diagnosed
- acinetobacter baumannii
- global health
- biofilm formation
- peritoneal dialysis
- prognostic factors
- health information
- tertiary care
- staphylococcus aureus
- klebsiella pneumoniae
- acute care
- gram negative
- methicillin resistant staphylococcus aureus
- health insurance
- smoking cessation
- social media
- infectious diseases